It Is Time for a Simplified Approach to Hepatitis B Elimination
Authors:
- Douglas DieterichDDDouglas Dieterich
- Camilla GrahamCGCamilla Graham
- Su WangSWSu Wang
- Paul KwoPKPaul Kwo
- Young-Suk LimYLYoung-Suk Lim
- Chun-Jen LiuCLChun-Jen Liu
- Kosh AgarwalKAKosh Agarwal
- Mark SulkowskiMSMark Sulkowski
Open Access
- 14 October 2022
- journal article
- research article
- Published by Elsevier in Gastro Hep Advances
- Vol. 2 (2) , 209-218
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 54 references indexed in Scilit:
- Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US PopulationClinical Gastroenterology and Hepatology, 2014
- Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care SettingDigestive Diseases and Sciences, 2014
- Prior Exposure to Lamivudine Increases Entecavir Resistance Risk in Chronic Hepatitis B Patients without Detectable Lamivudine ResistanceAntimicrobial Agents and Chemotherapy, 2014
- Hepatitis B Screening and Vaccination Practices in Asian American Primary CareGut and Liver, 2013
- Chronic HBV Infection outside Treatment Guidelines: Is Treatment Needed?Antiviral Therapy, 2013
- Low Rates of Hepatitis B Virus Screening at the Onset of ChemotherapyJournal of Oncology Practice, 2012
- The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United StatesClinical Infectious Diseases, 2011
- High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006